Research Article | | Peer-Reviewed

Epidemiological, Diagnostic and Evolutionary Profile of Stomach Cancer at Bogodogo University Hospital (Chub) in Ouagadougou (Burkina Faso)

Received: 27 November 2023     Accepted: 11 December 2023     Published: 22 December 2023
Views:       Downloads:
Abstract

Introduction: According to WHO estimates, in 2020 there will be over 1.1 million cases of stomach cancer, including 770,000 deaths, and it remains the third leading cause of cancer deaths worldwide. In Burkina Faso, Zoungrana et al. (2021) noted that stomach cancer ranked second among digestive cancers, with a prevalence of 74.28%. The aim of our study was to determine the epidemiological, diagnostic and evolutionary profile of stomach cancer in Ouagadougou. Patients and methods: This was a retrospective and descriptive study carried out in the Oncology and Clinical Hematology Department of CHUB in Ouagadougou from January 1, 2018 to December 31, 2022. We included in our study all patients who presented a stomach cancer confirmed by anatomo-pathological examination and who consulted in oncology and/or were hospitalized during the study period. Results: During the study period, 50 cases of gastric cancer were diagnosed, representing a hospital prevalence of 9.15%. The mean age of our patients was 57.6 years. The female gender was predominant (58% female). The most important risk factor was the consumption of salty foods (98%). Epigastric pain was the most frequent warning sign, found in 98% of patients, followed by vomiting (88%). Endoscopically, antral location was the most frequent with 58%. Adenocarcinoma was the most frequent histological appearance with 88%. The ulcerative-bourgeous aspect was the most frequent in 82% of patients. 66% of patients had secondary locations. The liver was the most frequent site of metastasis in 58% of patients. We found 66% of patients with stage IV pathology. In our study, 58% of patients received treatment, of which 83% of patients received palliative treatment. Surgical treatment was performed in 30%, partial gastrectomy in 80% of patients. In our study, 58% of patients received chemotherapy. The Folfox protocol was more used with 79.31%. At the end of our study, 32% of our patients were alive. The median survival was 2 months. Conclusion: Stomach cancer is not very common in our context. The implementation of awareness programs for the population is necessary.

Published in International Journal of Clinical Oncology and Cancer Research (Volume 8, Issue 4)
DOI 10.11648/j.ijcocr.20230804.14
Page(s) 101-106
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2023. Published by Science Publishing Group

Keywords

Stomach, Cancer, Ouagadougou

References
[1] Bolenga ALF, Kabore DD, Ndingossoka RJE, et al. Aspects Cliniques et Histologiques des Cancers de l ’ E stomac au Centre Hospitalier et Universitaire de Brazzaville. 2022; 65–68.
[2] Gnimien HS. Le cancer de l’estomac en milieu hospitalier à ouagadougou : approche endoscopique. Université Joseph Ki-Zerbo, 2020.
[3] Koné Y. Aspects epidemiologiques, cliniques et therapeutiques dans le service de chirurgie « A » au centre Hospitalo – Universitaire du point G. Université de Bamako, Mali, 2006.
[4] Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin 2021; 71: 209–249.
[5] Kouriba S. Le cancer de l’estomac : Aspects épidémiologiques, diagnostiques, thérapeutiques et pronostiques dans le service de chirurgie générale du CHU Gabriel Touré. UNIVERSITE DES SCIENCES, DES TECHNIQUES ET DES TECHNOLOGIES DE BAMAKO, https://www.bibliosante.ml/handle/123456789/5049 (2021).
[6] Zoungrana S, Ouattara Z, Kambire J, et al. Les cancers gastriques dans les villes moyennes du Burkina Faso: Aspects épidémiologiques et diagnostiques (à propos de 52 cas). Jaccr Africa 2021; 5: 165–172.
[7] Kissi A-KH, Bangoura A, Fanou C, et al. Les cancers digestifs au CHU de Yopougon (Côte d’Ivoire) : aspects Diagnostiques et thérapeutiques. Digestive cancers in the teachinghospital of Yopougon (Côte d’Ivoire): Diagnostic and therapeutic aspects. Rev Int des Sci Médicales d’Abidjan 2016; 16: 82–87.
[8] Youssouf O, Diarra M, Samake K, et al. Aspects Épidémiologiques, Cliniques Et Histologiques Du Cancer De L’estomac Au CHU Gabriel Touré de Bamako (Mali). Eur Sci Journal, ESJ 2022; 18: 123.
[9] Ouedraogo S, Ouedraogo S, Luc KJ, et al. Profil épidémiologique, clinique, histologique et thérapeutique des cancers digestifs primitifs dans les régions nord et est du Burkina Fas. Bull Cancer 2018; 105: 1119–1125.
[10] Bouglouga O, Lawson-Ananissoh LM, Bagny A, et al. Cancer de l’estomac : aspects épidémiologiques, cliniques et histologiques au CHU Campus de Lomé (Togo). Med Sante Trop; 25. Epub ahead of print 2015. DOI: https://www.jle.com/10.1684/mst.2014.0415.
[11] Bassène ML, Sy D, Dia D, et al. Le cancer gastrique : étude descriptive de 101 casdans le centre d’endoscopie digestive du CHUAristide Le Dantec. Me ́decine Sante ́Tropicale 2014; 25: 377–380.
[12] Mabula JB, Mchembe MD, Koy M, et al. Gastric cancer at a university teaching hospital in northwestern Tanzania: A retrospective review of 232 cases. World J Surg Oncol 2012; 10: 1–10.
[13] James DL, Adamou. H, Chaibou MS, et al. Les cancers gastriques: Aspects cliniques, thérapeutiques et pronostiques dans un service à moyens limités à l’Hôpital National de Niamey James. nnales l’Université Abdou Moumouni Niamey, Série A Sci exactes, Nat Agron la santé; Tome XXI,.
[14] Bang G, Djopseu L, Chasim C B, et al. Cancers Digestifs Opérés au Cameroun : Typologie et Stadification au Moment du Diagnostic Digestive cancers operated in Cameroon : typology and stag eing at the time of diagnosis. 2021; 22: 11–15.
[15] Amar BI, Sahraoui N, Masmi A. L’adénocarcinome gastrique au niveau du service Hépato- gastro-entérologie CHU Tlemcen. Université Abou Bekr Belkaid –Tlemcen, http://dspace.univ-tlemcen.dz/bitstream/112/16047/1/l-adenocarcinome-gastrique-au-niveau-du-service-hepato-gastro-enterologie-CHU-Tlemcen.pdf (2018).
[16] Koura M, Some RO, Ouattara DZ, et al. Le cancer de l’estomac dans un pays d’Afrique sub-saharienne : aspects épidémiologiques, anatomocliniques et endoscopiques à Bobo-Dioulasso (Burkina Faso). Sci Tech Sci la Santé 2019; 42: 79–86.
[17] Bah M, Traore B, Boni JP, et al. Aspects diagnostiques et thérapeutiques des cancers de l’estomac en milieu oncologique à Conakry. Sci Tech; 13, https://www.ajol.info/index.php/racs/article/view/189320 (2019).
[18] Diop B, Sow O, Thiam O, et al. Prise en Charge Chirurgicale des Tumeurs Gastriques à Dakar : à Propos de 36 Observations Surgical management of gastric cancer at Dakar. A report of 36 cases. Heal J Dis 2017; 18: 34–38.
[19] Kpossou AR, Gbessi DG, Gnangnon FHR, et al. Epidemiology of primitive digestive cancers in adult in three specialized health centers in Cotonou (Benin Republic). Bull la Soc Pathol Exot 2020; 113: 254–257.
[20] Shin A, Kim J, Park S. Gastric cancer epidemiology in Korea. J Gastric Cancer 2011; 11: 135–140.
[21] INSD. Annuaire statistiques 2014. Ouagadougou, Burkina Faso: Institut national de la statistique et de la démographie, http://www.insd.bf/n/contenu/pub_periodiques/annuaires_stat/Annuaires_stat_nationaux_BF/Annuaire_stat_2014.pdf. Décembre 2015 (2015).
[22] Ismaili N, Zaidi H, Elkacemi H, et al. Epidemiological, clinical, pathological, and therapeutic aspects of gastric cancer in Morocco. Clin Cancer Investig J 2014; 4: 3.
[23] Matallah N, Dalil Z. Cancer de l’estomac. Université Abou Bekr Belkaid Tlemcen, http://dspace.univ-tlemcen.dz/bitstream/112/16134/1/cacer-de-l-estomac.pdf (2019).
[24] Tangara D. Cancer de l’estomac : aspects diagnostiques et thérapeutiques dans le service de chirurgie « A » de 2010 à 2018. Université des Sciences des Techniques et des Technologies de Bamako, 2020.
[25] Bang GA, Savom EP, Oumarou BN, et al. Clinical epidemiology and mortality risk factors of gastric cancer in a sub-saharan african setting: A retrospective analysis of 120 cases in Yaoundé (Cameroon). Pan Afr Med J 2020; 37: 1–14.
[26] Kim J, Park S, Nam BH. Gastric cancer and salt preference: A population-based cohort study in Korea. Am J Clin Nutr 2010; 91: 1289–1293.
[27] Giraud P, Trédaniel J. Cancérologie – 3e édition. Collège Na. Paris, https://www.med-line.fr/back-future-fine/uploads/2021/06/Extrait-CANCERO-R2C-1.pdf (2021).
[28] Bekolo-Nga WT, Bagnaka SAE, Ndam AWN, et al. Facteurs Pronostiques du Cancer de l ’ Estomac au Cameroun : Cas des Hôpitaux Généraux de Douala et de Yaoundé Prognostic factors of gastric cancer in Cameroon : Case of the General Hospitals of Douala and Yaounde. Heal Sci Dis 2022; 23: 3–7.
[29] Chevallay M, Jung M, Morel P, et al. Cancer de l’estomac : prise en charge et traitement multidisciplinaire. Rev Med Suisse 2018; 14: 2221–2225.
[30] Fadlouallah M, Krami H, Errabih I, et al. Le cancer gastrique : aspects épidémiologiques au Maroc. J Africain du Cancer / African J Cancer 2015; 1: 8–15.
Cite This Article
  • APA Style

    Hierrhum Aboubacar, B., Nina Assanatou Jumelle, Z., SoniaYasmina, K., Aboubacar, C., Maurice, Z. (2023). Epidemiological, Diagnostic and Evolutionary Profile of Stomach Cancer at Bogodogo University Hospital (Chub) in Ouagadougou (Burkina Faso). International Journal of Clinical Oncology and Cancer Research, 8(4), 101-106. https://doi.org/10.11648/j.ijcocr.20230804.14

    Copy | Download

    ACS Style

    Hierrhum Aboubacar, B.; Nina Assanatou Jumelle, Z.; SoniaYasmina, K.; Aboubacar, C.; Maurice, Z. Epidemiological, Diagnostic and Evolutionary Profile of Stomach Cancer at Bogodogo University Hospital (Chub) in Ouagadougou (Burkina Faso). Int. J. Clin. Oncol. Cancer Res. 2023, 8(4), 101-106. doi: 10.11648/j.ijcocr.20230804.14

    Copy | Download

    AMA Style

    Hierrhum Aboubacar B, Nina Assanatou Jumelle Z, SoniaYasmina K, Aboubacar C, Maurice Z. Epidemiological, Diagnostic and Evolutionary Profile of Stomach Cancer at Bogodogo University Hospital (Chub) in Ouagadougou (Burkina Faso). Int J Clin Oncol Cancer Res. 2023;8(4):101-106. doi: 10.11648/j.ijcocr.20230804.14

    Copy | Download

  • @article{10.11648/j.ijcocr.20230804.14,
      author = {Bambara Hierrhum Aboubacar and Zerbo Nina Assanatou Jumelle and Kouraogo SoniaYasmina and Coulibaly Aboubacar and Zida Maurice},
      title = {Epidemiological, Diagnostic and Evolutionary Profile of Stomach Cancer at Bogodogo University Hospital (Chub) in Ouagadougou (Burkina Faso)},
      journal = {International Journal of Clinical Oncology and Cancer Research},
      volume = {8},
      number = {4},
      pages = {101-106},
      doi = {10.11648/j.ijcocr.20230804.14},
      url = {https://doi.org/10.11648/j.ijcocr.20230804.14},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijcocr.20230804.14},
      abstract = {Introduction: According to WHO estimates, in 2020 there will be over 1.1 million cases of stomach cancer, including 770,000 deaths, and it remains the third leading cause of cancer deaths worldwide. In Burkina Faso, Zoungrana et al. (2021) noted that stomach cancer ranked second among digestive cancers, with a prevalence of 74.28%. The aim of our study was to determine the epidemiological, diagnostic and evolutionary profile of stomach cancer in Ouagadougou. Patients and methods: This was a retrospective and descriptive study carried out in the Oncology and Clinical Hematology Department of CHUB in Ouagadougou from January 1, 2018 to December 31, 2022. We included in our study all patients who presented a stomach cancer confirmed by anatomo-pathological examination and who consulted in oncology and/or were hospitalized during the study period. Results: During the study period, 50 cases of gastric cancer were diagnosed, representing a hospital prevalence of 9.15%. The mean age of our patients was 57.6 years. The female gender was predominant (58% female). The most important risk factor was the consumption of salty foods (98%). Epigastric pain was the most frequent warning sign, found in 98% of patients, followed by vomiting (88%). Endoscopically, antral location was the most frequent with 58%. Adenocarcinoma was the most frequent histological appearance with 88%. The ulcerative-bourgeous aspect was the most frequent in 82% of patients. 66% of patients had secondary locations. The liver was the most frequent site of metastasis in 58% of patients. We found 66% of patients with stage IV pathology. In our study, 58% of patients received treatment, of which 83% of patients received palliative treatment. Surgical treatment was performed in 30%, partial gastrectomy in 80% of patients. In our study, 58% of patients received chemotherapy. The Folfox protocol was more used with 79.31%. At the end of our study, 32% of our patients were alive. The median survival was 2 months. Conclusion: Stomach cancer is not very common in our context. The implementation of awareness programs for the population is necessary.
    },
     year = {2023}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - Epidemiological, Diagnostic and Evolutionary Profile of Stomach Cancer at Bogodogo University Hospital (Chub) in Ouagadougou (Burkina Faso)
    AU  - Bambara Hierrhum Aboubacar
    AU  - Zerbo Nina Assanatou Jumelle
    AU  - Kouraogo SoniaYasmina
    AU  - Coulibaly Aboubacar
    AU  - Zida Maurice
    Y1  - 2023/12/22
    PY  - 2023
    N1  - https://doi.org/10.11648/j.ijcocr.20230804.14
    DO  - 10.11648/j.ijcocr.20230804.14
    T2  - International Journal of Clinical Oncology and Cancer Research
    JF  - International Journal of Clinical Oncology and Cancer Research
    JO  - International Journal of Clinical Oncology and Cancer Research
    SP  - 101
    EP  - 106
    PB  - Science Publishing Group
    SN  - 2578-9511
    UR  - https://doi.org/10.11648/j.ijcocr.20230804.14
    AB  - Introduction: According to WHO estimates, in 2020 there will be over 1.1 million cases of stomach cancer, including 770,000 deaths, and it remains the third leading cause of cancer deaths worldwide. In Burkina Faso, Zoungrana et al. (2021) noted that stomach cancer ranked second among digestive cancers, with a prevalence of 74.28%. The aim of our study was to determine the epidemiological, diagnostic and evolutionary profile of stomach cancer in Ouagadougou. Patients and methods: This was a retrospective and descriptive study carried out in the Oncology and Clinical Hematology Department of CHUB in Ouagadougou from January 1, 2018 to December 31, 2022. We included in our study all patients who presented a stomach cancer confirmed by anatomo-pathological examination and who consulted in oncology and/or were hospitalized during the study period. Results: During the study period, 50 cases of gastric cancer were diagnosed, representing a hospital prevalence of 9.15%. The mean age of our patients was 57.6 years. The female gender was predominant (58% female). The most important risk factor was the consumption of salty foods (98%). Epigastric pain was the most frequent warning sign, found in 98% of patients, followed by vomiting (88%). Endoscopically, antral location was the most frequent with 58%. Adenocarcinoma was the most frequent histological appearance with 88%. The ulcerative-bourgeous aspect was the most frequent in 82% of patients. 66% of patients had secondary locations. The liver was the most frequent site of metastasis in 58% of patients. We found 66% of patients with stage IV pathology. In our study, 58% of patients received treatment, of which 83% of patients received palliative treatment. Surgical treatment was performed in 30%, partial gastrectomy in 80% of patients. In our study, 58% of patients received chemotherapy. The Folfox protocol was more used with 79.31%. At the end of our study, 32% of our patients were alive. The median survival was 2 months. Conclusion: Stomach cancer is not very common in our context. The implementation of awareness programs for the population is necessary.
    
    VL  - 8
    IS  - 4
    ER  - 

    Copy | Download

Author Information
  • UFR/SDS, Joseph KI-Zerbo University, Ouagadougou, Burkina Faso; Clinical Hematology Oncology Service, CHU Bogodogo, Ouagadougou, Burkina Faso

  • Clinical Hematology Oncology Service, CHU Bogodogo, Ouagadougou, Burkina Faso

  • Clinical Hematology Oncology Service, CHU Bogodogo, Ouagadougou, Burkina Faso

  • UFR/SDS, Joseph KI-Zerbo University, Ouagadougou, Burkina Faso; Gastro-Hepatoenterology Service, CHU Yalgado Ouedraogo, Ouagadougou, Burkina Faso

  • UFR/SDS, Joseph KI-Zerbo University, Ouagadougou, Burkina Faso; General and Digestive Surgery Service, CHU Yalgado Ouedraogo, Ouagadougou, Burkina Faso

  • Sections